KARYN TETLOFF: Open Payments
NPI 1487156808 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,842 in 78 payments from 31 companies in 2025. Trend: 2023 $502 · 2024 $1,211 · 2025 $1,842
Food & beverage: $1,842
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 11 | $204 |
| Biogen, Inc. | 7 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $126 |
| Aucta Pharmaceuticals, Inc. | 5 | $103 |
| SK Life Science, Inc. | 3 | $97 |
| Eisai Inc. | 4 | $97 |
| Genentech USA, Inc. | 3 | $86 |
| ABBVIE INC. | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| ARGENX US, INC. | 3 | $81 |
Products named: TYSABRI, HYQVIA, Fintepla, Motpoly XR, Leqembi, KESIMPTA, VYVGART HYTRULO, ONPATTRO.
Industry payments across MI — which companies pay providers there.
